首页> 外文OA文献 >PRS35 EFFECT OF THE REPLACEMENT OF INHALED CORTICOSTEROIDS BY LONG-ACTING ANTICHOLINERGICS IN DUAL THERAPY ON HEALTH OUTCOMES IN PATIENTS WITH COPD: A REAL-LIFE RETROSPECTIVE STUDY

【2h】

PRS35 EFFECT OF THE REPLACEMENT OF INHALED CORTICOSTEROIDS BY LONG-ACTING ANTICHOLINERGICS IN DUAL THERAPY ON HEALTH OUTCOMES IN PATIENTS WITH COPD: A REAL-LIFE RETROSPECTIVE STUDY

机译：PRS35通过长效抗胆碱剂在患有COPD患者的健康结果中替代吸入皮质类固醇的影响：真实的回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A. Sicras-Mainar; R. Navarro-Artieda; J.L. Enriquez;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Impact of long-acting bronchodilators and exposure to inhaled corticosteroids on mortality in COPD: A real-life retrospective cohort study [J] . ManoharanA., ShortP.M., AndersonW.J., Lung. . 2014,第5期

机译：长效支气管扩张药和吸入皮质类固醇激素暴露对COPD死亡率的影响：一项真实的回顾性队列研究
2. Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting βsub2/sub-agonist via dry-powder inhalers and pressurized metered-dose inhalers [J] . Eric T Wittbrodt, Lauren A Millette, Kristin A Evans, International Journal of Chronic Obstructive Pulmonary Disease . 2018,第1期

机译：干粉吸入器和加压定量吸入器吸入糖皮质激素/长效β_{2 激动剂治疗的COPD患者出院后卫生保健结果的差异}
3. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO) [J] . Andrea Rossi, Massimo Guerriero, Antonio Corrado, Respiratory Research . 2014,第1期

机译：吸入糖皮质激素的戒断对于低加重风险的COPD患者是安全的：一项关于中度COPD患者治疗是否适当的现实研究（OPTIMO）
4. An Individual Patient Outcome Tool for Joint Replacement Patients [C] . Peter ELLISON, Paul John HOL Ankica BABIC ICIMTH . 2018

机译：用于联合替代患者的个体患者结果工具
5. Addition of leukotriene receptor antagonists versus long acting beta agonists to inhaled corticosteroid therapy for asthma treatment in older adults: A retrospective data analysis of effectiveness, safety and cost. [D] . Altawalbeh, Shoroq Mahmoud. 2015

机译：在吸入性糖皮质激素治疗中，将白三烯受体拮抗剂与长效β激动剂相比，用于老年人的哮喘治疗：有效性，安全性和成本的回顾性数据分析。
6. Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers [O] . Eric T Wittbrodt, Lauren A Millette, Kristin A Evans, 2019

机译：经干粉吸入器和加压定量吸入器吸入皮质类固醇/长效β2-激动剂治疗的COPD出院后患者的医疗保健结果差异
7. RS1 A RETROSPECTIVE, OBSERVATIONAL STUDY COMPARING OUTCOMES OF ASTHMATREATMENT WITH FIXED COMBINATIONS OF INHALED CORTICOSTEROID AND LONG-ACTING â2-AGONIST (ICS/LABA) IN REAL-LIFE PRACTICE [O] . Thomas M, Von Ziegenweidt J, Wirén A, 2007

机译：RS1回顾性，观察性研究，比较了在实际生活中采用吸入性糖皮质激素和长效α2-激动剂（ICS / LABA）固定组合进行哮喘治疗的结果

PRS35 EFFECT OF THE REPLACEMENT OF INHALED CORTICOSTEROIDS BY LONG-ACTING ANTICHOLINERGICS IN DUAL THERAPY ON HEALTH OUTCOMES IN PATIENTS WITH COPD: A REAL-LIFE RETROSPECTIVE STUDY

著录项

引文网络

相似文献

相关主题

期刊订阅